BiotechTube
Home/Calyxo/Chris Buchko, PhD, JD
CB

Chris Buchko, PhD, JD

General Counsel

Calyxo

Therapeutic Areas

UrologyNephrolithiasis (Kidney Stones)

Calyxo Pipeline

DrugIndicationPhase
CVAC System / SURE ProcedureKidney Stone Treatment (Nephrolithiasis)Approved

Leadership Team at Calyxo

JC
Joe Catanese III, PhD
President and Chief Executive Officer
JS
Jee Shin
Founder and Chief Business Officer
DH
Doug Hughes
Chief Financial Officer
LC
Lisa Campbell
Vice President, People
RC
Ryan Connolly
Senior Vice President, Research and Development
View full Calyxo profile